ArTS Archivio della ricerca di Trieste

LASSIANI, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.837
EU - Europa 2.025
AS - Asia 1.784
SA - Sud America 180
Continente sconosciuto - Info sul continente non disponibili 168
AF - Africa 89
OC - Oceania 12
Totale 8.095
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.801
SG - Singapore 614
CN - Cina 484
PL - Polonia 419
SE - Svezia 336
IT - Italia 316
UA - Ucraina 259
VN - Vietnam 176
HK - Hong Kong 159
FR - Francia 134
BR - Brasile 130
DE - Germania 122
KR - Corea 118
FI - Finlandia 108
RU - Federazione Russa 77
GB - Regno Unito 75
TR - Turchia 58
BD - Bangladesh 45
IE - Irlanda 44
BG - Bulgaria 41
IN - India 37
MA - Marocco 33
SN - Senegal 30
NL - Olanda 21
AR - Argentina 18
BE - Belgio 18
CA - Canada 18
JP - Giappone 16
ES - Italia 13
AU - Australia 10
IQ - Iraq 10
MX - Messico 10
EC - Ecuador 9
ID - Indonesia 9
HR - Croazia 7
SA - Arabia Saudita 7
ZA - Sudafrica 7
CH - Svizzera 6
IL - Israele 6
JO - Giordania 6
LT - Lituania 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
PK - Pakistan 5
CO - Colombia 4
ET - Etiopia 4
KE - Kenya 4
PE - Perù 4
PY - Paraguay 4
BS - Bahamas 3
DZ - Algeria 3
EU - Europa 3
LB - Libano 3
RO - Romania 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CL - Cile 2
GA - Gabon 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
TH - Thailandia 2
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GH - Ghana 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
UY - Uruguay 1
Totale 7.930
Salva come PNG Salva come JPEG
Città #
Ann Arbor 518
Singapore 380
Warsaw 378
Woodbridge 378
Ashburn 301
Chandler 258
Houston 241
Jacksonville 225
Fairfield 212
San Jose 207
Hong Kong 153
Wilmington 145
Beijing 134
Hefei 112
Seoul 112
Trieste 96
Seattle 93
Princeton 80
Cambridge 76
Columbus 74
Boardman 65
Council Bluffs 62
Chicago 55
Santa Clara 52
Izmir 49
Ho Chi Minh City 48
Los Angeles 48
Dublin 44
Lauterbourg 43
Sofia 40
Hanoi 38
Dallas 36
Zgierz 36
Milan 35
Moscow 32
Casablanca 31
Dakar 30
Munich 29
Buffalo 28
The Dalles 28
Düsseldorf 27
Bremen 25
Frankfurt am Main 22
New York 22
Turku 19
Brussels 18
San Diego 17
Dearborn 16
Helsinki 15
London 15
Shanghai 15
Phoenix 14
São Paulo 14
Tokyo 14
Orem 12
Brooklyn 9
Guangzhou 9
Nanjing 9
Norwalk 9
Da Nang 8
Falls Church 8
Foligno 8
Kunming 8
Mestre 8
Mumbai 8
Padova 8
Roubaix 8
San Francisco 8
Shenyang 8
Tianjin 8
Philadelphia 7
Des Moines 6
Miano 6
North Bergen 6
Nuremberg 6
Redondo Beach 6
Rio de Janeiro 6
Toronto 6
Verona 6
Amman 5
Atlanta 5
Bologna 5
Curitiba 5
Haiphong 5
Jinan 5
Montreal 5
St Petersburg 5
Sydney 5
Addis Ababa 4
Baghdad 4
Biên Hòa 4
Chennai 4
Dhaka 4
Dong Ket 4
Fuzhou 4
Jiaxing 4
Johannesburg 4
Kocaeli 4
Lima 4
Mexico City 4
Totale 5.539
Salva come PNG Salva come JPEG
Nome #
Improving Biopharmaceutical Properties of Vinpocetine Through Cocrystallization 429
Rapidly-Disintegrating Laminar Extrudates: Preliminary Experiments upon an Age Appropriate Pediatric Formulation 412
New Anthranilic Acid Based Antagonists with High Affinity and Selectivity for the Human Cholecystokinin Receptor 1 (hCCK1-R) 323
Anthranilic acid derivatives: A new class of non-peptide CCK1 receptor antagonists 265
Chemical probes for the adenosine receptors 244
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 243
C-terminal anthranoyl-anthranilic acid derivatives and their evaluation on CCK receptors. 240
Synthesis of N-terminal substituted anthranilic acid dimer derivatives for evaluation on CCK receptors. 235
ANTHRANILIC ACID BASED CCK1 RECEPTOR ANTAGONISTS AND CCK-8 HAVE A COMMON STEP IN THEIR "RECEPTOR DESMODYNAMIC PROCESSES" 230
Anthranilic acid based CCK1 receptor antagonists: Blocking the receptor with the same ‘words’ of the endogenous ligand 228
Synthesis and antitumor activity of α-alkyliden-γ-lactones 225
Anthranilic acid based CCK1 antagonists: the 2-indole moiety may represent a “needle” according to the recent homonymous concept. 224
Chemometric investigation of antitumor tests 222
Antiinflammatory action of hydrosoluble dimethyltriazenes on the carrageenin-induced edema in guinea pigs 222
Anthranyl derivatives having an anticholecystokinin activity (anti-CCK1), a process for their preparation, and pharmaceutical use thereof 212
Anthranilic acid based CCK1 receptor antagonists 210
N-TERMINAL ANTHRANOYL-PHENYLALANINE DERIVATIVES AS CCK1 RECEPTOR ANTAGONISTS: THE FINAL APPROACH 206
Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes 204
Effect of High Hydrostatic Pressare on Cathalytic Behaviour of Pseudomonas Lipase 200
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 198
Kinetic study of the hydrolysis of 1-(4-nitrophenyl)-3-methyltriazene in aqueous solution and in the presence of surfactants 196
Anthranoyl-anthranilic acid: A template for the development of a new class of cholecystokinin receptor ligands. 191
2D-QSAR and 3D-QSAR/CoMFA analyses of the N-terminal substituted anthranilic acid based CCK1 receptor antagonists: ‘Hic Rhodus, hic saltus’ 189
Effects of isomeric aryldimethyl-triazenes on Lewis lung carcinoma growth and metastases in mice 185
Anthranyl derivatives having an anticholecystokinin activity (anti-CCK1), a process for their preparation, and pharmaceutical use thereof. 182
TWENTY YEARS OF NON-PEPTIDE CCK1 RECEPTOR ANTAGONISTS: ALL THAT GLITTERS IS NOT GOLD 181
Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma 172
Anthranilic Acid Based CCK1 Receptor Antagonists: Preliminary Investigation On Their Second “Touch point” 169
Kinetic investigation of the aqueous stability and antitumor activity of a hydrosoluble diaryltriazene, AVIS, related to the antimetastatic agent DM-COOK 165
Anthranyl derivatives having an anticholecystokinin activity (anti-CCK1), a process for their preparation, and pharmaceutical use thereof 164
Metabolism and mechanism of the antileukemic action of isomeric aryldimethyltriazenes. 153
Novel Anthranilic Acid Derivates with Nanomolar CCK-A Receptor Affinity 152
Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt 149
Synthesis of 1-aryl-3-formyl-3-methyltriazenes, potential metabolites of 1-aryl-3,3-dimethyltriazenes. 140
Synthesis of new anthranilic acid dimer derivatives and their evaluation on CCK receptors. 138
Mechanism of the antimetastatic action of dimethyltriazenes. 132
Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma. 131
Metastasis: mitostatic drugs 122
Synthesis and antitumor activity of hydrosoluble analogs of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt 114
Synthesis and antitumor activity of hydrosoluble triazenes, analogs of DM-COOK 98
Totale 8.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.375
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.375
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022501 0 0 20 74 10 46 19 14 63 59 44 152
2022/2023718 80 111 46 112 75 128 1 66 66 4 20 9
2023/2024331 16 14 31 22 43 6 46 95 4 6 34 14
2024/2025896 16 41 35 75 87 87 60 35 121 118 101 120
2025/20262.175 231 123 182 246 193 212 301 67 212 277 57 74
2026/2027222 37 126 59 0 0 0 0 0 0 0 0 0
Totale 8.095